OpenVSafe by OpenVAERS
Search V-safe

FEC-95633-78396

3 vaccinations 2 coded responses 11 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
208 / MD
Registered
2022-01-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-28
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-05
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-06
    Registered in v-safe
  5. 2022-01-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  6. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  7. 2022-01-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  8. 2022-01-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2022-01-15
    Health check-in — day 7, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2022-01-22
    Survey response — day 14, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-22
    Report sent to call center — day 14, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  12. 2022-01-25
  13. 2022-01-26
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-02-02
    Survey response — day 28, dose 3
    MedDRA: Headache, Heart rate increased, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Rapid heart beat and headaches · Healthcare visit (other): Office visit for EKG
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-02-02
    Report sent to call center — day 28, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2022-02-04
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  17. 2022-04-06
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-07-06
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2023-01-07
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Pfizer-BioNTech No
22021-04-28Pfizer-BioNTech No
32022-01-05Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 11 — day 14, dose 3

2022-01-22

Symptoms: COVID

Release 11 — day 28, dose 3

2022-02-02

Symptoms: Rapid heart beat and headaches
Healthcare visit (other): Office visit for EKG

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDCOVID-19 · · ✓
SDHeadache · · ✓
SDHeart rate increased · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release